LifeMD, Inc.·4

Jan 28, 2:46 PM ET

Benathen Marc David 4

4 · LifeMD, Inc. · Filed Jan 28, 2022

Insider Transaction Report

Form 4
Period: 2022-01-27
Benathen Marc David
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-01-27+25,00052,554 total
  • Exercise/Conversion

    Restricted Stock Unit

    2022-01-2725,00050,000 total
    Common Stock (25,000 underlying)
  • Award

    Restricted Stock Unit

    2022-01-27+75,00075,000 total
    Exercise: $0.00Common Stock (75,000 underlying)
Footnotes (2)
  • [F1]25,000 RSUs vested on January 27, 2022. Of the remaining RSUs, 25,000 vest on January 27, 2023 and 25,000 vest on January 27, 2024.
  • [F2]Restricted stock units convert into common stock on a one-for-one basis.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT